| Product Code: ETC7378225 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of pneumococcal vaccines to Grenada in 2024 show a diversification in the top exporting countries, with Barbados, India, Panama, South Korea, and Belgium leading the way. The Herfindahl-Hirschman Index (HHI) indicates a shift from high to moderate concentration, reflecting a more balanced market. With a remarkable Compound Annual Growth Rate (CAGR) of 24.01% from 2020 to 2024 and a rapid growth rate of 67.54% from 2023 to 2024, the market for pneumococcal vaccines in Grenada is experiencing significant expansion and potential opportunities for further development.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Pneumococcal Vaccine Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Grenada Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Grenada Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Grenada Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Grenada Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Grenada Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Grenada Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Grenada Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Grenada |
4.2.2 Government initiatives to improve healthcare infrastructure and access to vaccines |
4.2.3 Rising prevalence of pneumococcal diseases in Grenada |
4.3 Market Restraints |
4.3.1 Limited healthcare budget and resources in Grenada |
4.3.2 Lack of adequate cold chain infrastructure for vaccine storage and distribution |
5 Grenada Pneumococcal Vaccine Market Trends |
6 Grenada Pneumococcal Vaccine Market, By Types |
6.1 Grenada Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Grenada Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Grenada Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Grenada Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Grenada Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Grenada Pneumococcal Vaccine Market Export to Major Countries |
7.2 Grenada Pneumococcal Vaccine Market Imports from Major Countries |
8 Grenada Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates in Grenada |
8.2 Number of healthcare facilities equipped with necessary resources for administering the pneumococcal vaccine |
8.3 Rate of adherence to national immunization schedules for pneumococcal vaccination. |
9 Grenada Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Grenada Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Grenada Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Grenada Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Grenada Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Grenada Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Grenada Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Grenada Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Grenada Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |